StockData
iBio, Inc. logo

iBio, Inc. (IBIO) stock

IBIONasdaqPharmaceutical PreparationsFiscal year ends June 30
Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 9/30
$0.85+0.10 (+13.37%)

Close on Nov 18, 2026Market cap $54.54MP/E –Yield –

iBio operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

iBio's operating income for the twelve months ending Sep 30, 2026 was -$37.53M. For fiscal 2026 it was -$35.14M. The highest annual figure on record is -$3.84M in fiscal 2014.

Annual operating income

PeriodPeriod endValueChange
FY2026Jun 30, 2026-$35.14M–
FY2025Jun 30, 2025-$18.60M–
FY2024Jun 30, 2024-$16.63M–
FY2023Jun 30, 2023-$29.34M–
FY2022Jun 30, 2022-$29.70M–
FY2021Jun 30, 2021-$31.11M–
FY2020Jun 30, 2020-$14.00M–
FY2019Jun 30, 2019-$15.79M–
FY2018Jun 30, 2018-$14.23M–
FY2017Jun 30, 2017-$14.27M–
FY2016Jun 30, 2016-$9.89M–
FY2015Jun 30, 2015-$6.67M–
FY2014Jun 30, 2014-$3.84M–
FY2013Jun 30, 2013-$6.67M–
FY2012Jun 30, 2012-$9.33M–
FY2011Jun 30, 2011-$9.65M–

Quarterly operating income

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2027CQ3 2026Sep 30, 2026-$8.34M–
Q4 FY2026CQ2 2026Jun 30, 2026-$11.38M–
Q3 FY2026CQ1 2026Mar 31, 2026-$8.37M–
Q2 FY2026CQ4 2025Dec 31, 2025-$9.45M–
Q1 FY2026CQ3 2025Sep 30, 2025-$5.95M–
Q4 FY2025CQ2 2025Jun 30, 2025-$5.20M–
Q3 FY2025CQ1 2025Mar 31, 2025-$4.88M–
Q2 FY2025CQ4 2024Dec 31, 2024-$4.42M–
Q1 FY2025CQ3 2024Sep 30, 2024-$4.11M–
Q4 FY2024CQ2 2024Jun 30, 2024-$3.41M–
Q3 FY2024CQ1 2024Mar 31, 2024-$3.63M–
Q2 FY2024CQ4 2023Dec 31, 2023-$4.50M–
Q1 FY2024CQ3 2023Sep 30, 2023-$5.10M–
Q4 FY2023CQ2 2023Jun 30, 2023-$4.97M–
Q3 FY2023CQ1 2023Mar 31, 2023-$6.17M–
Q2 FY2023CQ4 2022Dec 31, 2022-$10.57M–
Q1 FY2023CQ3 2022Sep 30, 2022-$7.64M–
Q4 FY2022CQ2 2022Jun 30, 2022-$10.45M–
Q3 FY2022CQ1 2022Mar 31, 2022-$6.79M–
Q4 FY2021CQ2 2021Jun 30, 2021-$9.44M–
Q3 FY2021CQ1 2021Mar 31, 2021-$7.20M–
Q2 FY2021CQ4 2020Dec 31, 2020-$7.55M–
Q1 FY2021CQ3 2020Sep 30, 2020-$6.92M–
Q4 FY2020CQ2 2020Jun 30, 2020-$2.93M–
Q3 FY2020CQ1 2020Mar 31, 2020-$4.06M–
Q2 FY2020CQ4 2019Dec 31, 2019-$3.16M–
Q1 FY2020CQ3 2019Sep 30, 2019-$3.86M–
Q4 FY2019CQ2 2019Jun 30, 2019-$4.05M–
Q3 FY2019CQ1 2019Mar 31, 2019-$3.77M–
Q2 FY2019CQ4 2018Dec 31, 2018-$4.02M–
Q1 FY2019CQ3 2018Sep 30, 2018-$3.95M–
Q4 FY2018CQ2 2018Jun 30, 2018-$3.95M–
Q3 FY2018CQ1 2018Mar 31, 2018-$3.49M–
Q2 FY2018CQ4 2017Dec 31, 2017-$3.43M–
Q1 FY2018CQ3 2017Sep 30, 2017-$3.36M–
Q4 FY2017CQ2 2017Jun 30, 2017-$3.86M–
Q3 FY2017CQ1 2017Mar 31, 2017-$3.94M–
Q2 FY2017CQ4 2016Dec 31, 2016-$3.33M–
Q1 FY2017CQ3 2016Sep 30, 2016-$3.15M–

More iBio figures

See a number that looks wrong?